
Ilomastat
Ilomastat is an N-acyl-amino acid obtained by formal condensation of the carboxy group of (2R)-2-[2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoic acid with the amino group of N-methyl-L-tryptophanamide. A cell permeable broad-spectrum matrix metalloproteinase (MMP) inhibitor. It has a role as an antibacterial agent, an antineoplastic agent, a neuroprotective agent, an anti-inflammatory agent and an EC 3.4.24.24 (gelatinase A) inhibitor. It is a hydroxamic acid, a L-tryptophan derivative and a N-acyl-amino acid. — ChEBI
- IUPAC name
- (2R)-N'-hydroxy-N-[(2S)-3-(1H-indol-3-yl)-1-(methylamino)-1-oxopropan-2-yl]-2-(2-methylpropyl)butanediamide
- Molecular formula
- C20H28N4O4
- Molecular weight
- 388.5 g/mol
- Exact mass
- 388.21105539 Da
- XLogP3
- 0.9
- Topological polar surface area
- 123.0 Ų
- Hydrogen-bond donors
- 5
- Hydrogen-bond acceptors
- 4
- Covalent units
- 1
- Defined stereocentres
- 2
Also known as
16 more reported names
External database identifiers
- ChEBI:CHEBI:137236
- ChEMBL:CHEMBL19611
- EPA DTXSID:DTXSID0046353
- PubMed:35687819
- PubMed:34626302
- PubMed:30549224
- PubMed:26908177
- PubMed:26490843
- PubMed:24555532
- PubMed:23894327
- PubMed:23525277
- PubMed:23462309
- PubMed:23047022
- PubMed:22581348
- PubMed:22155090
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.